Most Wall Street professionals obsess over short-term returns. However, patient individual investors who buy and hold leading ...

Lægemiddelstyrelsen i USA, FDA, har tirsdag godkendt Novo Nordisks diabetesmiddel Ozempic til behandling af kronisk ...

Ozempic er nu godkendt af FDA til behandling af patienter med kronisk nyresygdom i USA, hvilket udvider dets anvendelse ud ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Microsoft og vores tredjepartsleverandører bruger cookies til at gemme og få adgang til oplysninger, som f.eks. entydige ...

Now Novo Nordisk is required to provide insulin products at $35 per monthly prescription for customers paying with cash. The settlement also requires all three companies to use a texting system to ...

ST. PAUL, Minn. – Minnesota Attorney General Keith Ellison settled with insulin manufacturers Eli Lilly, Sanofi, and Novo ...

Minnesota A.G. Keith Ellison says his office settled with Novo Nordisk to cap monthly out-of-pocket payments for insulin at ...

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about ...

Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare ...